2,4-二甲基-1-戊醇 | 6305-71-1

• 分子结构分类: 有机化合物 - 有机氧化合物
• 中文名称: 2,4-二甲基-1-戊醇
• 英文名称: 2,4-dimethyl-1-pentanol
• 英文别名: 2,4-dimethylpentanol；2,4-dimethylpentan-1-ol
• CAS: 6305-71-1
• 化学式: C₇H₁₆O
• mdl: MFCD00022001
• 分子量: 116.203
• InChiKey: OVOVDHYEOQJKMD-UHFFFAOYSA-N

物化性质

• 熔点：
  -30.45°C (estimate)
• 沸点：
  157.85°C
• 密度：
  0.8150

计算性质

• 辛醇/水分配系数(LogP)：
  2
• 重原子数：
  8
• 可旋转键数：
  3
• 环数：
  0.0
• sp3杂化的碳原子比例：
  1.0
• 拓扑面积：
  20.2
• 氢给体数：
  1
• 氢受体数：
  1

安全信息

• 海关编码：
  2905199090

反应信息

• 作为反应物：
  描述：

  2,4-二甲基-1-戊醇 在 吡啶 、 magnesium 、 lithium bromide 作用下， 以 四氢呋喃 、 二氯甲烷 、 丙酮 为溶剂， 反应 4.0h， 生成 4,6-二甲基-1-庚醇
  参考文献：
  名称：

  Neutral compounds from male castoreum of North American beaver,Castor canadensis

  摘要：

  North American beavers (Casio, canadensis) mark their territories with castoreum, the strong-smelling paste in their castor sacs. In their own territories, beavers respond with scent marking to experimental scent marks that consist of strange castoreum (or selected components). In part, the unique odor of castoreum is due to large amounts of phenolic compounds rind neutral compounds. Purifed neutral compounds were analyzed by GC, GC-MS, and NMR; identities of the neutral compounds were confirmed by comparing the properties of authentic compounds with those of the isolated compounds. We identified 13 neutral compounds that had not been reported before for castoreum. Most of these are oxygen-containing monoterpenes, Of the nine neutral compounds reported by Lederer (1949), only three are confirmed in our analysis; the other six neutral compounds are either absent or are not volatile enough to be detected by our methods. Eight compounds-6-methyl-1-heptanol, 4,6-dimethyl-1-heptanol, isopinocamphone, pinocamphone, two linalool oxides, and their acetates-were synthesized for structure identification and bioassays.

  DOI：

  10.1007/bf02033674
• 作为产物：
  描述：

  ethyl 2,4-dimethyl-4-pentenoate 在 palladium on activated charcoal lithium aluminium tetrahydride 、 氢气 作用下， 以 乙醚 、 乙醇 为溶剂， 反应 2.0h， 生成 2,4-二甲基-1-戊醇
  参考文献：
  名称：

  Neutral compounds from male castoreum of North American beaver,Castor canadensis

  摘要：

  North American beavers (Casio, canadensis) mark their territories with castoreum, the strong-smelling paste in their castor sacs. In their own territories, beavers respond with scent marking to experimental scent marks that consist of strange castoreum (or selected components). In part, the unique odor of castoreum is due to large amounts of phenolic compounds rind neutral compounds. Purifed neutral compounds were analyzed by GC, GC-MS, and NMR; identities of the neutral compounds were confirmed by comparing the properties of authentic compounds with those of the isolated compounds. We identified 13 neutral compounds that had not been reported before for castoreum. Most of these are oxygen-containing monoterpenes, Of the nine neutral compounds reported by Lederer (1949), only three are confirmed in our analysis; the other six neutral compounds are either absent or are not volatile enough to be detected by our methods. Eight compounds-6-methyl-1-heptanol, 4,6-dimethyl-1-heptanol, isopinocamphone, pinocamphone, two linalool oxides, and their acetates-were synthesized for structure identification and bioassays.

  DOI：

  10.1007/bf02033674
• 作为试剂：
  描述：

  辛烯 在 双(乙腈)氯化钯(II) 、 1-hydroxytetraphenylcyclopentadienyl(tetraphenyl-2,4-cyclopentadien-1-one)-μ-hydrotetracarbonyldiruthenium(II) 叔丁基对苯醌 、 水 、 copper dichloride 、 2,4-二甲基-1-戊醇 作用下， 以 叔丁醇 为溶剂， 反应 32.0h， 以34%的产率得到辛醇
  参考文献：
  名称：

  CATALYTIC ANTI-MARKOVNIKOV OXIDATION AND HYDRATION OF OLEFINS

  摘要：

  该披露提供了一个用于将烯烃直接转化为醇的双催化系统。这个合作催化系统包含一个氧化催化剂和一个转移氢化催化剂。可以使用多种烯烃作为反应物，包括芳香族和脂肪族烯烃。转化反应具有反Markovnikov选择性，并在某些方面提供主要产物为一级醇。该披露进一步提供了一个具有反Markovnikov选择性的烯烃氧化系统。

  公开号：

  US20120172634A1

文献信息

• HETEROCYCLIC INHIBITORS OF ERK1 AND ERK2 AND THEIR USE IN THE TREATMENT OF CANCER
  申请人：Asana Biosciences, LLC

  公开号：US20160362407A1

  公开（公告）日：2016-12-15

  The present application provides novel heterocyclic compounds and pharmaceutically acceptable salts thereof. Also provided are methods for preparing these compounds. These compounds are useful for inhibiting ERK1/2. By administering to a patient in need a therapeutically effective amount of one or more of the compounds of formula (I), wherein X, Y, Z, J, M, and R 1 to R 8 are defined herein, these compounds are effective in treating conditions associated with dysregulation of the RAS/RAF/MEK/ERK pathway. A variety of conditions can be treated using these compounds and include diseases which are characterized by abnormal cellular proliferation. In one embodiment, the disease is cancer.

  本申请提供了新颖的杂环化合物及其药用可接受的盐。还提供了制备这些化合物的方法。这些化合物对抑制ERK1/2有用。通过向需要治疗的患者施用式(I)的一个或多个化合物的治疗有效量，其中X、Y、Z、J、M和R1至R8在此处定义，这些化合物在治疗与RAS/RAF/MEK/ERK通路失调相关的疾病方面是有效的。可以使用这些化合物治疗各种疾病，包括以异常细胞增殖为特征的疾病。在一个实施例中，该疾病是癌症。
• Fe(III) Complex Compounds For The Treatment And Prophylaxis Of Iron Deficiency Symptoms And Iron Deficiency Anemias
  申请人：Bark Thomas

  公开号：US20130109662A1

  公开（公告）日：2013-05-02

  The invention relates to iron(III) complex compounds and pharmaceutical compositions comprising them for the use as medicaments, in particular for the treatment and/or prophylaxis of iron deficiency symptoms and iron deficiency anemias.

  这项发明涉及铁（III）配合物和包括它们的药物组合物，用作药物，特别是用于治疗和/或预防缺铁症状和缺铁性贫血。
• TOLL LIKE RECEPTOR MODULATOR COMPOUNDS
  申请人：Gilead Sciences, Inc.

  公开号：US20160289229A1

  公开（公告）日：2016-10-06

  The present disclosure relates generally to toll like receptor modulator compounds, such as diamino pyrido[3,2 D]pyrimidine compounds and pharmaceutical compositions which, among other things, modulate toll-like receptors (e.g. TLR-8), and methods of making and using them.

  本公开涉及调节类似受体调节剂化合物，例如二氨基吡啶并[3,2 D]嘧啶化合物和药物组合物，其中调节类似受体（例如TLR-8），以及制备和使用它们的方法。
• Prodrug derivatives of acids using alcohols with homotopic hydroxy groups and methods for their preparation and use
  申请人：deLong A. Mitchell

  公开号：US20070254920A1

  公开（公告）日：2007-11-01

  This invention relates to novel homotopic prodrugs and medicaments and methods for their preparation, testing and use. In one embodiment, the homotopic prodrug has the general formula wherein is a biologically-active moiety comprising a carboxylic acid functional group, and R b is a homotopically-symmetrical alcohol bonded to the biologically-active moiety through the carboxylic acid functional group to form an ester linkage, as well as optical isomers, enantiomers, pharmaceutically acceptable salts, biohydrolyzable amides, esters, and imides thereof and combinations thereof.

  这项发明涉及新型同位素前药、药物以及其制备、测试和使用方法。在一个实施例中，同位素前药具有一般公式 其中 是包含羧酸官能团的生物活性基团，而 R b 是通过羧酸官能团与生物活性基团形成酯键的同位对称醇，以及其光学异构体、对映异构体、药用可接受盐、生物水解酰胺、酯、亚酰胺及其组合物。
• [EN] INHIBITORS OF UDP-GALACTOPYRANOSE MUTASE THWART MYCOBACTERIAL GROWTH<br/>[FR] INHIBITEURS DE UDP-GALACTOPYRANOSE EMPÊCHANT LA CROISSANCE MYCOBACTÉRIENNE
  申请人：WISCONSIN ALUMNI RES FOUND

  公开号：WO2009132310A1

  公开（公告）日：2009-10-29

  Compounds which inhibit microbial growth or attenuate the virulence of pathogen microorganisms. Compounds of the invention inhibit UDP-galactopyranose mutase (UGM) and have activity as inhibitors of microbial growth of microorganisms which contain this enzyme and particularly those microorganisms in which this enzyme is responsible for the incorporation of galactofuranose residues, particularly for uridine 5'-diphosphate (UDP) galactopyranose mutase. Compounds of the invention inhibit UDP- galactopyranose mutase (UGM) and have activity to attenuate virulence of pathogenic microorganisms, including mycobacteria.

  抑制微生物生长或减弱病原微生物毒力的化合物。本发明的化合物抑制UDP-半乳糖吡喃糖醇异构酶（UGM），并具有抑制含有该酶的微生物生长的活性，特别是那些该酶负责将半乳糖呋喃糖醇残基纳入其中的微生物，特别是尿苷5'-二磷酸（UDP）半乳糖吡喃糖醇异构酶。本发明的化合物抑制UDP-半乳糖吡喃糖醇异构酶（UGM），并具有减弱病原微生物毒力的活性，包括分枝杆菌。